Ming-Ming He
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 20
- Colorectal Cancer Treatments and Studies 8
- Cancer Immunotherapy and Biomarkers 6
-
- Cancer Genomics and Diagnostics 6
- Cancer-related molecular mechanisms research 4
- Co-authors
- Rui‐Hua Xu (26 shared papers)Feng Wang (16 shared papers)Ying Jin (13 shared papers)Qi Zhao (7 shared papers)Ze-Xian Liu (3 shared papers)Hui Luo (15 shared papers)Ying-Nan Wang (2 shared papers)Mingyang Song (8 shared papers)
- Journals
- Nature Communications (3 papers)JAMA Oncology (2 papers)Epidemiology and Infection (2 papers)Medicine (2 papers)International Journal of Cancer (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ming-Ming He
58 papers receiving 2.3k citations
Ming-Ming He's Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 718
- Oncology 779
- Pathology and Forensic Medicine 241
- Pulmonary and Respiratory Medicine 359
- Molecular Biology 636
Countries citing papers authored by Ming-Ming He
This map shows the geographic impact of Ming-Ming He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Ming He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Ming He more than expected).
Fields of papers citing papers by Ming-Ming He
This network shows the impact of papers produced by Ming-Ming He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Ming He. The network helps show where Ming-Ming He may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming-Ming He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types Hit paper breakdown → | 2019 | 332 |
| 2 | 2018 | 295 | |
| 3 | 2020 | 161 | |
| 4 | 2015 | 144 | |
| 5 | 2021 | 128 | |
| 6 | 2019 | 102 | |
| 7 | 2020 | 88 | |
| 8 | 2021 | 86 | |
| 9 | 2015 | 65 | |
| 10 | 2015 | 64 | |
| 11 | 2020 | 61 | |
| 12 | 2020 | 57 | |
| 13 | 2022 | 54 | |
| 14 | 2022 | 51 | |
| 15 | 2022 | 45 | |
| 16 | 2019 | 44 | |
| 17 | 2021 | 39 | |
| 18 | 2023 | 39 | |
| 19 | 2015 | 36 | |
| 20 | Anti-PD-1 antibody SHR-1210 plus apatinib for metastatic colorectal cancer: a prospective, single-arm, open-label, phase II trial. | 2020 | 34 |
About Ming-Ming He
Ming-Ming He is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Epidemiology and Gastroenterology, having authored 63 papers that have together received 2.3k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Genomics and Diagnostics (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Metastasis and carcinoma case studies (4 papers), Pneumonia and Respiratory Infections (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (718 citations), Oncology (779 citations), Pathology and Forensic Medicine (241 citations), Pulmonary and Respiratory Medicine (359 citations) and Molecular Biology (636 citations). Ming-Ming He has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Rui‐Hua Xu, Feng Wang, Ying Jin, Qi Zhao, Ze-Xian Liu, Hui Luo, Ying-Nan Wang, Mingyang Song, De‐Shen Wang and Chao Ren. Their work appears in journals such as Nature Communications, JAMA Oncology, Epidemiology and Infection, Medicine and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.